872 related articles for article (PubMed ID: 27092773)
21. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.
Zhu H; Leiss L; Yang N; Rygh CB; Mitra SS; Cheshier SH; Weissman IL; Huang B; Miletic H; Bjerkvig R; Enger PØ; Li X; Wang J
Oncotarget; 2017 Feb; 8(7):12145-12157. PubMed ID: 28076333
[TBL] [Abstract][Full Text] [Related]
22. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
23. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
Hutter G; Theruvath J; Graef CM; Zhang M; Schoen MK; Manz EM; Bennett ML; Olson A; Azad TD; Sinha R; Chan C; Assad Kahn S; Gholamin S; Wilson C; Grant G; He J; Weissman IL; Mitra SS; Cheshier SH
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):997-1006. PubMed ID: 30602457
[TBL] [Abstract][Full Text] [Related]
24. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
25. Differential S1P Receptor Profiles on M1- and M2-Polarized Macrophages Affect Macrophage Cytokine Production and Migration.
Müller J; von Bernstorff W; Heidecke CD; Schulze T
Biomed Res Int; 2017; 2017():7584621. PubMed ID: 28367448
[No Abstract] [Full Text] [Related]
26. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
Wei J; Besner GE
J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
[TBL] [Abstract][Full Text] [Related]
27. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
28. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content.
Gunalp S; Helvaci DG; Oner A; Bursalı A; Conforte A; Güner H; Karakülah G; Szegezdi E; Sag D
Front Immunol; 2023; 14():1209249. PubMed ID: 37809073
[TBL] [Abstract][Full Text] [Related]
29. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
Gao C; Nie Y
Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
[TBL] [Abstract][Full Text] [Related]
30. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells
Brauneck F; Oliveira-Ferrer L; Muschhammer J; Sturmheit T; Ackermann C; Haag F; Schulze Zur Wiesch J; Ding Y; Qi M; Hell L; Schmalfeldt B; Bokemeyer C; Fiedler W; Wellbrock J
Front Immunol; 2023; 14():1250258. PubMed ID: 37876933
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages.
Tarique AA; Logan J; Thomas E; Holt PG; Sly PD; Fantino E
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):676-88. PubMed ID: 25870903
[TBL] [Abstract][Full Text] [Related]
33. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors.
Hsu SPC; Chen YC; Chiang HC; Huang YC; Huang CC; Wang HE; Wang YS; Chi KH
J Neurooncol; 2020 Feb; 146(3):417-426. PubMed ID: 32020472
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytes.
Olsson M; Nilsson A; Oldenborg PA
Biochem Biophys Res Commun; 2007 Jan; 352(1):193-7. PubMed ID: 17112468
[TBL] [Abstract][Full Text] [Related]
36. High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.
Schaper F; de Leeuw K; Horst G; Bootsma H; Limburg PC; Heeringa P; Bijl M; Westra J
Rheumatology (Oxford); 2016 Dec; 55(12):2260-2270. PubMed ID: 27632996
[TBL] [Abstract][Full Text] [Related]
37. A fully human anti-CD47 blocking antibody with therapeutic potential for cancer.
Zeng D; Sun Q; Chen A; Fan J; Yang X; Xu L; Du P; Qiu W; Zhang W; Wang S; Sun Z
Oncotarget; 2016 Dec; 7(50):83040-83050. PubMed ID: 27863402
[TBL] [Abstract][Full Text] [Related]
38. Palmitate differentially regulates the polarization of differentiating and differentiated macrophages.
Xiu F; Diao L; Qi P; Catapano M; Jeschke MG
Immunology; 2016 Jan; 147(1):82-96. PubMed ID: 26453839
[TBL] [Abstract][Full Text] [Related]
39. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses.
Wang YC; He F; Feng F; Liu XW; Dong GY; Qin HY; Hu XB; Zheng MH; Liang L; Feng L; Liang YM; Han H
Cancer Res; 2010 Jun; 70(12):4840-9. PubMed ID: 20501839
[TBL] [Abstract][Full Text] [Related]
40. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro.
Shiratori H; Feinweber C; Luckhardt S; Linke B; Resch E; Geisslinger G; Weigert A; Parnham MJ
Mol Immunol; 2017 Aug; 88():58-68. PubMed ID: 28600970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
